Vaccine Safety

C19 Vax Strategy: Geert Vanden Bossche and Robert Malone, MD

The Safety of COVID-19 Vaccinations - We Should Rethink the Policy

June 24, 2021


Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. 

Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register ( to extract the number of cases reporting severe side effects and the number of cases with fatal side effects.